US BioDesign Launches Cardiovascular Biomaterials Business Segment

PERKASIE, Pa.--(BUSINESS WIRE)--US BioDesign announced today the launch of its cardiovascular biomaterials business segment. This portion of US BioDesign will be responsible for the research, analysis and production of products and services in the cardiovascular device area. This includes OEM components for all cardiovascular products, including cardiac and peripheral stents, vascular grafts and stent grafts, vascular access devices, pacemakers, and accessory products for heart valves.

MORE ON THIS TOPIC